NGVT icon

Ingevity

31.11 USD
-0.47
1.49%
At close Apr 21, 4:00 PM EDT
After hours
31.11
+0.00
0.00%
1 day
-1.49%
5 days
-4.78%
1 month
-26.59%
3 months
-34.82%
6 months
-7.96%
Year to date
-21.32%
1 year
-35.01%
5 years
-17.48%
10 years
32.38%
 

About: Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Employees: 1,600

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 75

6% more capital invested

Capital invested by funds: $1.4B [Q3] → $1.49B (+$87.3M) [Q4]

1.58% more ownership

Funds ownership: 99.07% [Q3] → 100.66% (+1.58%) [Q4]

3% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 33

2% less funds holding

Funds holding: 260 [Q3] → 255 (-5) [Q4]

32% less call options, than puts

Call options by funds: $77K | Put options by funds: $114K

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$32
3%
upside
Avg. target
$49
56%
upside
High target
$65
109%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Wells Fargo
Michael Sison
21% 1-year accuracy
11 / 53 met price target
3%upside
$32
Equal-Weight
Maintained
9 Apr 2025
BMO Capital
John McNulty
20% 1-year accuracy
9 / 46 met price target
109%upside
$65
Outperform
Upgraded
26 Feb 2025

Financial journalist opinion

Positive
Zacks Investment Research
2 weeks ago
Here's Why You Should Add Ingevity Stock to Your Portfolio
NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Here's Why You Should Add Ingevity Stock to Your Portfolio
Positive
Zacks Investment Research
1 month ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
Neutral
Business Wire
1 month ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting.
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
Negative
Zacks Investment Research
1 month ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Positive
Zacks Investment Research
1 month ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
1 month ago
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Ingevity (NGVT) is a Top Growth Stock for the Long-Term
Neutral
Business Wire
1 month ago
Ingevity announces appointment of David H. Li as president and CEO
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025.
Ingevity announces appointment of David H. Li as president and CEO
Positive
Zacks Investment Research
1 month ago
Here's What Makes Ingevity Stock a Solid Choice Right Now
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.
Here's What Makes Ingevity Stock a Solid Choice Right Now
Neutral
Zacks Investment Research
1 month ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International
Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International
Positive
Zacks Investment Research
1 month ago
5 Stocks With Upgraded Broker Ratings Worth Betting on Now
Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL.
5 Stocks With Upgraded Broker Ratings Worth Betting on Now
Charts implemented using Lightweight Charts™